18 results on '"Zhang, Jinghai"'
Search Results
2. Size effect of mesoporous silica nanoparticles on regulating the immune effect of oral influenza split vaccine.
- Author
-
Liu Z, Lu H, Li S, Liu B, Zhao Q, Gao Y, Mao Y, Zhang J, and Wang S
- Subjects
- Animals, Administration, Oral, Porosity, Mice, Adjuvants, Immunologic chemistry, Adjuvants, Immunologic pharmacology, Adjuvants, Immunologic administration & dosage, Mice, Inbred BALB C, Female, Immunity, Mucosal drug effects, Surface Properties, Silicon Dioxide chemistry, Influenza Vaccines immunology, Influenza Vaccines chemistry, Influenza Vaccines administration & dosage, Nanoparticles chemistry, Particle Size
- Abstract
Mucosal immunization is a powerful weapon against viral infection. In this paper, large pore mesoporous silica nanoparticles (LMSN) with different particle sizes were synthesized for loading influenza split vaccine (SV) to explore the effect of nanoparticle sizes on mucosal immunization and adjuvant efficacy. Interestingly, it was found that among the three particle sizes of nanoparticles, only LMSN-M with around 250 nm could significantly enhance the mucosal immune effect of SV, possessing adjuvant effect. The results indicated that particle size affected the adjuvant effect of LMSN. There was no apparent difference in vaccine loading capacity of LMSN with different particle sizes, but the release of SV depended on the pore length of LMSN. The adjuvant effect of LMSN-M was attributed to its higher cellular uptake performance, intestine absorption and transport efficiency, and the ability to stimulate the maturation of dendritic cells. Simultaneously, compared with LMSN-S and LMSN-L, the more retention of LMSN-M in mesenteric lymph nodes increased the chance of interaction between vaccine and immune system, resulting in the enhanced immunity. This is the first time to study the impact of particle size of LMSN adjuvant on improving mucosal immunity of oral influenza vaccine, and the present work provides a scientific reference for adjuvant design of oral vaccine., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
3. NhaA: A promising adjuvant target for colistin against resistant Escherichia coli.
- Author
-
Wang X, Cui Y, Wang Z, Jiang H, Ma L, Li W, Yang X, Zhang J, Zhao Y, and Li G
- Subjects
- Animals, Anti-Bacterial Agents pharmacology, Microbial Sensitivity Tests, Drug Resistance, Bacterial drug effects, Mice, Escherichia coli Infections drug therapy, Escherichia coli Infections microbiology, Colistin pharmacology, Escherichia coli drug effects, Escherichia coli Proteins metabolism
- Abstract
The emergence and widespread of multidrug-resistant Gram-negative bacteria have posed a severe threat to human health and environmental safety, escalating into a global medical crisis. Utilization of antibiotic adjuvants is a rapid approach to combat bacterial resistance effectively since the development of new antimicrobial agents is a formidable challenge. NhaA, driven by proton motive force, is a crucial secondary transporter on the cytoplasmic membrane of Escherichia coli. We found that 2-Aminoperimidine (2-AP), which is a specific inhibitor of NhaA, could enhance the activity of colistin against sensitive E. coli and reverse the resistance in mcr-1 positive E. coli. Mechanistic studies indicated that 2-AP induced dysfunction in cytoplasmic membrane through the suppression of NhaA, leading to metabolic inhibition and ultimately enhancing the sensitivity of E. coli to colistin. Moreover, 2-AP restored the efficacy of colistin against resistant E. coli in two animal infection models. Our findings reveal the potential of NhaA as a novel target for colistin adjuvants, providing new possibilities for the clinical application of colistin., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could influence the work reported in this article., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
4. Erratum: Author correction to "Immune-awakening Saccharomyces -inspired nanocarrier for oral target delivery to lymph and tumors" [Acta Pharmaceutica Sinica B 12 (2022) 4501-4518].
- Author
-
Mao Y, Wang X, Chen C, Zhao Q, Liu Y, Zhang J, and Wang S
- Abstract
[This corrects the article DOI: 10.1016/j.apsb.2022.04.018.]., (© 2023 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF
5. Current trends in gas-synergized phototherapy for improved antitumor theranostics.
- Author
-
Yan Z, Liu Z, Zhang H, Guan X, Xu H, Zhang J, Zhao Q, and Wang S
- Subjects
- Humans, Precision Medicine, Phototherapy methods, Gases therapeutic use, Combined Modality Therapy, Cell Line, Tumor, Neoplasms pathology, Photochemotherapy, Nanoparticles therapeutic use
- Abstract
Phototherapy, such as photothermal therapy (PTT) and photodynamic therapy (PDT), has been considered an elegant solution to eradicate tumors due to its minimal invasiveness and low systemic toxicity. Nevertheless, it is still challenging for phototherapy to achieve ideal outcomes and clinical translation due to its inherent drawbacks. Owing to the unique biological functions, diverse gases have attracted growing attention in combining with phototherapy to achieve super-additive therapeutic effects. Specifically, gases such as nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H
2 S) have been proven to kill tumor cells by inducing mitochondrial damage in synergy with phototherapy. Additionally, several gases not only enhance the thermal damage in PTT and the reactive oxygen species (ROS) production in PDT but also improve the tumor accumulation of photoactive agents. The inflammatory responses triggered by hyperthermia in PTT are also suppressed by the combination of gases. Herein, we comprehensively review the latest studies on gas-synergized phototherapy for cancer therapy, including (1) synergistic mechanisms of combining gases with phototherapy; (2) design of nanoplatforms for gas-synergized phototherapy; (3) multimodal therapy based on gas-synergized phototherapy; (4) imaging-guided gas-synergized phototherapy. Finally, the current challenges and future opportunities of gas-synergized phototherapy for tumor treatment are discussed. STATEMENT OF SIGNIFICANCE: 1. The novelty and significance of the work with respect to the existing literature. (1) Strategies to design nanoplatforms for gas-synergized anti-tumor phototherapy have been summarized for the first time. Meanwhile, the integration of various imaging technologies and therapy modalities which endow these nanoplatforms with advanced theranostic capabilities has been summarized. (2) The mechanisms by which gases synergize with phototherapy to eradicate tumors are innovatively and comprehensively summarized. 2. The scientific impact and interest. This review elaborates current trends in gas-synergized anti-tumor phototherapy, with special emphases on synergistic anti-tumor mechanisms and rational design of therapeutic nanoplatforms to achieve this synergistic therapy. It aims to provide valuable guidance for researchers in this field., Competing Interests: Declaration of Competing Interest The authors declare there is no conflict of interests., (Copyright © 2023 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
6. Immune-awakenin g Saccharomyces -inspired nanocarrier for oral target delivery to lymph and tumors.
- Author
-
Mao Y, Wang X, Chen C, Zhao Q, Liu Y, Zhang J, and Wang S
- Abstract
Utilization of the intestinal lymphatic pathway will allow extraordinary gains in lymph and tumors cascade-targeted delivery of oral drugs and awakening the innate/adaptive immunity of the body and the lesion microenvironment, in addition to improving oral bioavailability relative to other means of delivery of oral drugs. Here, inspired by the specific invasion route of intestinal microorganisms, we pioneered an immune-awakening Saccharomyces -inspired mesoporous silicon nanoparticle (yMSN) for the ingenious cascade-targeted delivery of therapeutic cancer vaccines and antitumor drugs to lymph and tumors via the intestinal lymphatic pathway. Encouragingly, yMSN high-loaded tumor-specific antigens (OVA, 11.9%) and anti-tumor drugs (Len, 28.6%) with high stability, namely Len/OVA/yMSN, efficiently co-delivered OVA and Len to their desired target sites. Moreover, yMSN concomitantly awakened the innate antitumor immunity of dendritic cells and macrophages, strengthening vaccine-induced adaptive immune responses and reversing macrophage-associated immunosuppression in the tumor microenvironment. Surprisingly, Len/OVA/yMSN treatment resulted in excellent synergistic antitumor efficacy and long-term antitumor memory in OVA-Hepa1-6-bearing mice. This high-performance nanocarrier provides a novel approach for lesion-targeting delivery of oral drugs accompanied with awakening of the innate/adaptive immunity of the lesion environment, and also represents a novel path for the oral delivery of diverse therapeutic agents targeting other lymph-mediated diseases., Competing Interests: The authors have no conflicts of interest to declare., (© 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.)
- Published
- 2022
- Full Text
- View/download PDF
7. Prediction and verification of potential lead analgesic and antiarrhythmic components in Corydalis yanhusuo W. T. Wang based on voltage-gated sodium channel proteins.
- Author
-
Sun J, Liu X, Zhao S, Zhang S, Yang L, Zhang J, Zhao M, and Xu Y
- Subjects
- Analgesics pharmacology, Analgesics therapeutic use, Anti-Arrhythmia Agents, Molecular Docking Simulation, Pain, Plant Extracts chemistry, Corydalis chemistry, Drugs, Chinese Herbal chemistry, Drugs, Chinese Herbal pharmacology, Voltage-Gated Sodium Channels
- Abstract
Corydalis yanhusuo W. T. Wang, a traditional Chinese herbal medicine, has been used as an analgesic for thousands of years and it also promotes blood circulation. In this study, 33 Corydalis yanhusuo alkaloid active components were acquired from Traditional Chinese Medicine Database and Analysis Platform (TCMSP). A total of 543 pain-related targets, 1774 arrhythmia targets, and 642 potential targets of these active components were obtained using Swiss Target Prediction, GeneCards, Open Target Platform, and Therapeutic Target Database. Fifty intersecting targets were visualized through a Venn diagram, KEGG and GO pathway enrichment analysis. The analysis proposed that sodium ion channels are likely potential targets of Corydalis yanhusuo active components as analgesia and anti-arrhythmia agents. Molecular docking showed that the 33 components could bind to Nav1.7 and Nav1.5 (two subtypes of ion channel proteins) with different binding energies. In a patch clamp study, dihydrosanguinarine and dihydrochelerythrine, two monomers with the strongest binding effects, could inhibit the peak currents and promote both activation and inactivation phases of Nav1.5. Meanwhile, dihydrosanguinarine and dihydrochelerythrine could also inhibit peak currents and promote the activation phase of Nav1.7. Therefore, the findings from this study provide valuable information for future uses of traditional Chinese medicines to treat pain and cardiovascular disease., (Copyright © 2022 Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
8. Analysis of CFTR gene expression as an immunological and prognostic biomarker in pan-cancers.
- Author
-
Wang Q, Jia S, Zheng J, Xiang R, Cui Y, Zhang J, Xu Y, and Zhao M
- Subjects
- Biomarkers, Tumor genetics, Biomarkers, Tumor metabolism, Gene Expression, Humans, Prognosis, Cystic Fibrosis Transmembrane Conductance Regulator genetics, Cystic Fibrosis Transmembrane Conductance Regulator metabolism, Neoplasms genetics, Neoplasms metabolism
- Abstract
Cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-activated chloride channel that regulates fluid homeostasis via ATP binding and uses energy to transport relevant substrates across cytomembranes. It has been reported that CFTR plays a crucial role in the incidence and development of various types of cancers by regulating proliferation, metastasis, invasion and apoptosis. However, aberrant CFTR gene expression across different cancers makes it difficult to propose CFTR as a possible pan-cancer biomarker. Here, multiple databases (ONCOMINE, PrognoScan, Genotype-Tissue Expression (GTEx) and The Cancer Genome Atlas (TCGA)), were accessed to investigate the relationship between CFTR gene expression with the immunological and prognostic roles in pan-cancers. The results showed higher CFTR gene expression in tumor tissues compared to normal tissues for most cancers except for CHOL, ESCA, KICH, LAML, SKCM and STAD. Higher expression of the CFTR gene directly correlated with better prognosis for BRCA, GBM, COAD, KIRP, LAML, LUAD, PRAD, SARC and STAD, and CFTR gene expression was higher in stage Ⅰ_Ⅱ compared to stage Ⅲ_ Ⅳ. Furthermore, CFTR gene expression levels were significantly associated with immune infiltrates and immunocytes, in particular, immune checkpoints, in COAD, LIHC, LUAD and LUSC. In conclusion, CFTR can be used as a prognostic marker for nine types of cancers examined in this study where CFTR expression levels play a vital role in forecasting the clinical efficacy of immune checkpoint suppression therapy., (Copyright © 2022. Published by Elsevier Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
9. Identification of a novel protective human monoclonal antibody, LXY8, that targets the key neutralizing epitopes of staphylococcal enterotoxin B.
- Author
-
Hu N, Qiao C, Wang J, Wang Z, Li X, Zhou L, Wu J, Zhang D, Feng J, Shen B, Zhang J, and Luo L
- Subjects
- Animals, CHO Cells, Cell Proliferation, Cell Surface Display Techniques, Cricetulus, Cytokines metabolism, Enterotoxins antagonists & inhibitors, Epitope Mapping, Female, Histocompatibility Antigens Class II metabolism, Humans, Mice, Inbred BALB C, Protein Binding, Receptors, Antigen, T-Cell metabolism, Mice, Antibodies, Bacterial analysis, Antibodies, Monoclonal analysis, Antibodies, Neutralizing analysis, Enterotoxins immunology, Epitopes immunology
- Abstract
Staphylococcal enterotoxin B (SEB), one of the exotoxins produced by Staphylococcus aureus, is the key toxin that causes poisoning reactions and toxic shock syndrome. In the current research work, a novel human antibody named LXY8 was screened from a human phage display antibody library, and LXY8 blocked the interaction between SEB and the T cell receptor (TCR). The binding activity between LXY8 and SEB was 0.525 nM. Furthermore, LXY8 could effectively inhibit the SEB-induced activation of peripheral blood mononuclear cells and release of cytokines. In the BALB/c mouse model, LXY8 effectively neutralized SEB toxicity in vivo. Finally, based on computer-guided molecular modeling, we designed a series of SEB mutation sites; these sites facilitated the determination of the key residues (i.e.
176 EFNN179 ) of SEB recognized by LXY8. The research revealed that the176 EFNN179 residues of SEB are important for specific antibody-antigen recognition. The results may be helpful for the development of antibody-based therapy for SEB-induced toxic shock syndrome., Competing Interests: Declaration of competing interest Long L. Luo, Nai J. Hu, Chun X. Qiao, Jing Wang, Xin Y. Li, Jan N. Feng and Bei F. Shen have submitted patent applications pertaining to anti-SEB antibodies. The other authors declare no conflict of interest., (Copyright © 2021 Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
10. Regulatory effects of non-steroidal anti-inflammatory drugs on cardiac ion channels Nav1.5 and Kv11.1.
- Author
-
Xu Y, Li W, Han Y, Liu H, Zhang S, Yan J, Sun J, Liu Y, Zhang J, and Zhao M
- Subjects
- Animals, Anti-Inflammatory Agents, Non-Steroidal chemistry, CHO Cells, Cricetulus, HEK293 Cells, Humans, Ion Channel Gating drug effects, Kinetics, Anti-Inflammatory Agents, Non-Steroidal pharmacology, ERG1 Potassium Channel metabolism, NAV1.5 Voltage-Gated Sodium Channel metabolism
- Abstract
Non-steroidal Anti-inflammatory Drugs (NSAIDs) are widely used because of their excellent anti-inflammatory and analgesic effects. However, NSAIDs could cause certain cardiac side effects, such as myocardial infarction, heart failure, atrial fibrillation, arrhythmia and sudden cardiac death. Therefore, meloxicam, nimesulide, piroxicam, and diclofenac were selected and the whole cell patch clamp technique was used to investigate the electrophysiological regulatory effects of them on the sodium channel hNav1.5 and potassium channel hKv11.1, which were closely associated to the biotoxicity of cardiac, and to explore the potential cardiac risk mechanism. The results showed that the four NSAIDs could inhibit the peak currents of hNav1.5 and hKv11.1. Furthermore, the four NSAIDs could affect both the activation and inactivation processes of hNav1.5 with I-V curves left-shifted to hyperpolarized direction in activation phase. These data indicate that the inhibition effects of Nav1.5 and Kv11.1 by meloxicam, nimesulide, piroxicam, and diclofenac might contribute to their potential cardiac risk. These findings provide a basis for the discovery of other potential cardiac risk targets for NSAIDs., (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
11. Siglec1 enhances inflammation through miR-1260-dependent degradation of IκBα in COPD.
- Author
-
Li S, Jiang L, Yang Y, Cao J, Zhang Q, Zhang J, Wang R, Deng X, and Li Y
- Subjects
- 3' Untranslated Regions genetics, Animals, Cell Line, Cytokines metabolism, Disease Models, Animal, Down-Regulation genetics, Lung metabolism, Lung pathology, Male, MicroRNAs genetics, Protein Binding, RNA, Messenger genetics, RNA, Messenger metabolism, Rats, Rats, Sprague-Dawley, Inflammation genetics, MicroRNAs metabolism, NF-KappaB Inhibitor alpha metabolism, Proteolysis, Pulmonary Disease, Chronic Obstructive genetics, Sialic Acid Binding Ig-like Lectin 1 metabolism
- Abstract
It has been documented that sialic acid-binding Ig-like lectin 1 (Siglec1) is a cell surface protein with a variety of functions in the immune system. In the present study, we evaluated whether Siglec1 plays a role in chronic obstructive pulmonary disease (COPD). Results show that the expression of Siglec1 was increased in the lung of COPD rats, and that Siglec1 overexpression greatly enhanced the expression of inflammatory cytokines including tumor necrosis factor α (TNF-α), interleukin 1β (IL-1β) and IL-6 in cigarette smoke extract (CSE)-treated NR8383 cells, a rat lung-derived macrophage cell line. Notably, the proinflammatory effect of Siglec1 was totally inhibited by overexpression of nuclear factor of κ light polypeptide gene enhancer in B-cells inhibitor α (IκBα). Importantly, Siglec1 overexpression increased miR-1260, which then degraded IκBα through its 3' untranslated region (3'UTR). Further study demonstrated that miR-1260 inhibitor attenuated inflammation in CSE-induced rat COPD lung and in CSE-treated NR8383 cells. Finally, the inhibitory effect of miR-1260 on inflammation was totally lost when IκBα was inhibited. In summary, the present study demonstrated that Siglec1 exerts its proinflammatory effects through increasing miR-1260, leading to decreased expression of IκBα., (Copyright © 2020. Published by Elsevier Inc.)
- Published
- 2020
- Full Text
- View/download PDF
12. The diversity of pattern recognition receptors (PRRs) involved with insect defense against pathogens.
- Author
-
Wang X, Zhang Y, Zhang R, and Zhang J
- Subjects
- Animals, Bacteria, Biological Coevolution, Immunity, Innate, Insecta immunology, Insecta microbiology, Receptors, Pattern Recognition immunology
- Abstract
Through evolution, selection pressures cause both insects and the pathogens attacking them to adapt so that they will both survive and this has been called the co-evolutionary 'arms race'. Insects expand their repertoire of pattern recognition receptors (PRRs), a fundamental and core component of their immune systems, to adapt to the constantly changing and unpredictable diversity of pathogens. In this review, we discuss the diversity of PRRs based on studies conducted in recent years. The strategies associated with PRR diversity summarized here are genetic evolution, isoform diversity based on alternative splicing, 'part-time' PRRs, PRRs with opsonin function, and regulation of complex signaling pathways. Taken together, these data indicate that the function of PRRs in insect immunity is far more complex and possesses more features than originally thought., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
13. The role of the arginine residue in site RC for the analgesic activity of the recombinant Chinese scorpion Buthus martensii Karsch, BmK AGP-SYPU1.
- Author
-
Cui Y, Wang Y, Wang X, Zhang Z, Zhang J, and Zhao Y
- Subjects
- Analgesics administration & dosage, Analgesics chemistry, Animals, Arginine chemistry, Arginine genetics, China, Female, Injections, Intraperitoneal, Male, Mice, Mice, Inbred Strains, Models, Molecular, Mutagenesis, Site-Directed, Recombinant Proteins administration & dosage, Recombinant Proteins chemistry, Recombinant Proteins metabolism, Analgesics pharmacology, Arginine pharmacology, Scorpions chemistry
- Abstract
Scorpion venom is composed of a large number of bioactive peptides which display important pharmacological activities. In this study we have carried out a study of the functional role of the arginine residue at position 58 in the site RC comprising the reverse turn (8-12) and C-terminal residues 58-64. A polymerase chain reaction was used to substitute this arginine residue with a single amino acid such as alanine, glycine and lysine. The mutants were expressed in soluble form in E. coli, and purified by affinity chromatography. After target peptide purity identification, the recombinant peptides underwent a circular dichroism analysis and a study of their analgesic activity in mice. The results indicated that a single residue modification can affect the pharmacological activity. Our efforts establish a sound basis for further study of the structure-function determinants of the analgesic effect., (Copyright © 2018 Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
14. The roles of conserved aromatic residues (Tyr5 and Tyr42) in interaction of scorpion toxin BmK AGP-SYPU1 with human Na v 1.7.
- Author
-
Meng X, Xu Y, Wang F, Zhao M, Hou X, Ma Y, Jin Y, Liu Y, Song Y, and Zhang J
- Subjects
- Animals, CHO Cells, Cricetinae, Cricetulus, Humans, Kinetics, Models, Molecular, Mutation, Protein Binding, Protein Domains, Scorpion Venoms genetics, Structure-Activity Relationship, Conserved Sequence, NAV1.7 Voltage-Gated Sodium Channel metabolism, Scorpion Venoms chemistry, Scorpion Venoms metabolism, Scorpions, Tyrosine
- Abstract
Scorpion toxins are invaluable source of therapeutic leads and pharmacological tools which produce influence on the voltage gated sodium channels. In the previous study, our group has reported BmK AGP-SYPU1 (64 amino acids), one scorpion toxin with both potential α-type and β-type scorpion characteristics and analgesic activity in vivo, act as an activator to hNa
v 1.4 and hNav 1.5. Additionally, conserved aromatic amino acids Tyr5 and Tyr42 played important roles in bioactivity of BmK AGP-SYPU1 on hNav 1.4 and hNav 1.5. However, the anti-nonceptitor mechanisms of BmK AGP-SYPU1 referred in vivo have not been clarified yet. The roles of Tyr5 and Tyr42 have still kept unclear in the interaction of BmK AGP-SYPU1 with other VGSCs. In this study, in order to give a deep insight into the relationship of structure and function, the effects of BmK AGP-SYPU1 and its two mutants (Y5F and Y42F) on hNav 1.7, which has emerged as a key molecule involved in pain processing, were examined by using Na+ -specialized fluorescent dye and the whole-cell patch clamp. The data showed that BmK AGP-SYPU1 also displayed as an activator to hNav 1.7 with the potential characteristic of α-type and β-type scorpion toxin. Both Tyr5 and Tyr42 were the key amino acids to the functional properties of BmK AGP-SYPU1 when interacting with hNav 1.7, and the Tyr42 was involved in the preferences of the toxin to distinct action sites of hNav 1.7. On the whole, these data provided more information about the structure of BmK AGP-SYPU1 related to its function upon hNav 1.7, and may bring some clues for engineering scorpion toxins to achieve high bioactivity with lower side effects., (Copyright © 2017. Published by Elsevier B.V.)- Published
- 2017
- Full Text
- View/download PDF
15. A novel expression vector for the improved solubility of recombinant scorpion venom in Escherichia coli.
- Author
-
Han T, Ming H, Deng L, Zhu H, Liu Z, Zhang J, and Song Y
- Subjects
- Affinity Labels, Escherichia coli genetics, Genetic Enhancement, Recombinant Proteins biosynthesis, Recombinant Proteins chemistry, Scorpion Venoms chemistry, Solubility, Escherichia coli chemistry, Escherichia coli physiology, Genetic Vectors genetics, Protein Engineering methods, Scorpion Venoms biosynthesis, Scorpion Venoms genetics
- Abstract
Recombinant scorpion anti-excitation peptide (rANEP) has previously been expressed using the pET32a system and purified via affinity chromatography. However, rANEP is expressed in BL21(DE3) cells as an inclusion body, and the affinity tag can not be removed. To overcome this problem, we used a variety of protein, DsbA, MBP, TrxA, intein, and affinity tags in fusion and co-expression to achieve soluble and functional rANEP without any affinity tag. In the pCIT-ANEP expression vector, the highest soluble expression level was approximately 90% of the total cellular proteins in E. coli, and the rANEP was cleaved by the intein protein and subsequently purified to obtain rANEP, which had the same activity as the natural ANEP. The purity of rANEP obtained using this method was over 95%, with a quantity of 5.1 mg from of purified rANEP from 1 L of culture. This method could expand the application of the soluble expression of disulfide-rich peptides in E. coli., (Copyright © 2016. Published by Elsevier Inc.)
- Published
- 2017
- Full Text
- View/download PDF
16. AGAP, a new recombinant neurotoxic polypeptide, targets the voltage-gated calcium channels in rat small diameter DRG neurons.
- Author
-
Liu X, Li C, Chen J, Du J, Zhang J, Li G, Jin X, and Wu C
- Subjects
- Animals, Calcium Channels, T-Type physiology, Ganglia, Spinal physiology, Rats, Calcium Channels, T-Type drug effects, Ganglia, Spinal drug effects, Ion Channel Gating drug effects, Scorpion Venoms toxicity
- Abstract
A previous study showed that antitumor-analgesic peptide (AGAP), a novel recombinant polypeptide, which had been expressed in Escherichia coli, exhibits analgesic and antitumor effects in mice. In the present study, we investigated the underlying analgesic mechanism of AGAP. The effect of AGAP on voltage-gated calcium channels (VGCCs) was assessed in acutely isolated rat dorsal root ganglia (DRG) neurons using the whole-cell patch clamp technique. The results showed that AGAP potently inhibited VGCCs, especially high-voltage activated (HVA) calcium channels. AGAP inhibited HVA and T-type calcium currents in a dose-dependent manner, but had no significant effect on their dynamic functions in rat small-diameter DRG neurons. AGAP inhibited N- and L-type calcium currents at 78.2% and 57.3%, respectively. Thus, the present study demonstrates that AGAP affects calcium currents through the inhibition of N-, L- and T-type channels in DRG neurons, explaining the potential mechanisms of antinociception., (Copyright © 2014 Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
17. Kaempferol induces apoptosis in human HCT116 colon cancer cells via the Ataxia-Telangiectasia Mutated-p53 pathway with the involvement of p53 Upregulated Modulator of Apoptosis.
- Author
-
Li W, Du B, Wang T, Wang S, and Zhang J
- Subjects
- Apoptosis Regulatory Proteins, Ataxia Telangiectasia Mutated Proteins, Caspase 3 metabolism, Cell Line, Tumor, Cell Proliferation drug effects, Cell Survival drug effects, Collagen Type XI metabolism, Colonic Neoplasms metabolism, Colonic Neoplasms pathology, Cytochromes c metabolism, Dose-Response Relationship, Drug, Drug Screening Assays, Antitumor, Humans, Mitochondria drug effects, Mitochondria enzymology, Phosphorylation, Proto-Oncogene Proteins, Time Factors, Antineoplastic Agents pharmacology, Apoptosis drug effects, Cell Cycle Proteins metabolism, Colonic Neoplasms drug therapy, DNA-Binding Proteins metabolism, Kaempferols pharmacology, Protein Serine-Threonine Kinases metabolism, Tumor Suppressor Protein p53 metabolism, Tumor Suppressor Proteins metabolism
- Abstract
Dietary flavonols have been found to possess preventive and therapeutic potential against several kinds of cancers. This study is conducted to investigate the anti-proliferation effects of kaempferol, a major component of food flavonols, against colon cancer cells. In the human HCT116 colon cancer cell line, kaempferol induced p53-dependent growth inhibition and apoptosis. Furthermore, kaempferol was found to induce cytochrome c release from mitochondria and activate caspase-3 cleavage. The Bcl-2 family proteins including PUMA were involved in this process. Kaempferol also induced ATM and H2AX phosphorylation in HCT116 cells, inhibition of ATM by a chemical inhibitor resulted in abrogation of the downstream apoptotic cascades. These findings suggest kaempferol could be a potent candidate for colorectal cancer management.
- Published
- 2009
- Full Text
- View/download PDF
18. Positive regulation of tumor necrosis factor-alpha by ganglioside GM3 through Akt in mouse melanoma B16 cells.
- Author
-
Wang P, Wu P, Zhang J, Sato T, Yamagata S, and Yamagata T
- Subjects
- Androstadienes pharmacology, Animals, Chromones pharmacology, Mice, Morpholines pharmacology, Phosphorylation, Piperazines pharmacology, Signal Transduction drug effects, Signal Transduction physiology, Tumor Cells, Cultured, Tumor Necrosis Factor-alpha genetics, Wortmannin, G(M3) Ganglioside pharmacology, Melanoma pathology, Phosphoinositide-3 Kinase Inhibitors, Proto-Oncogene Proteins c-akt physiology, Skin Neoplasms pathology, Tumor Necrosis Factor-alpha metabolism
- Abstract
GM3 has been shown to suppress TNFalpha expression in blood monocytes. However, we found that GM3 and TNFalpha were expressed in parallel in mouse melanoma B16 cells that were transfected with UDP-Gal:glucosylceramide beta-1,4-galactosyltransferase cDNA in a sense or antisense direction or CMP-NeuAc:lactosylceramide alpha-2,3-sialyltransferase siRNA. TNFalpha expression was increased by addition of GM3 to the B16 transfectants and decreased after treatment with D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol, an inhibitor of glucosylceramide synthesis. These results clearly indicate that GM3 positively regulates TNFalpha expression in B16 cells. Phosphoinositide 3-kinase inhibitors, wortmannin and LY294,002, suppressed TNFalpha expression and Akt phosphorylation. GM3 was shown to increase phosphorylation of Akt in B16 cells and the B16-derived transfectants. Treatment of B16 cells with siRNA targeted to Akt1/2 resulted in TNFalpha suppression, indicating that Akt plays an important role in regulation of TNFalpha expression. Suppression of Akt1/2 rendered cells insensitive to GM3, suggesting that the GM3 signal may be transduced via Akt.
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.